Status:
RECRUITING
Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis
Lead Sponsor:
University Hospital Schleswig-Holstein
Conditions:
Atopic Dermatitis
Psoriasis
Eligibility:
All Genders
Up to 100 years
Brief Summary
The clinical study investigates the long-term course of disease in patients with chronic inflammatory skin diseases (atopic eczema and psoriasis) and the impact of tarheted therapies on the clinical a...
Detailed Description
Atopic dermatitis and psoriasis are the most common chronic inflammatory skin diseases in dermatology. Due to genetic predispositions, inflammatory changes of the skin occur. The specific mechanisms a...
Eligibility Criteria
Inclusion
- Patients with a clinical diagnosis of atopic dermatitis, psoriasis or autoimmune skin disease
- Written informed consent obtained from the subject
Exclusion
- Patients who decline participation
- In patients\<18 years of age no biopsies will be taken
Key Trial Info
Start Date :
March 16 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03361215
Start Date
March 16 2015
End Date
December 31 2030
Last Update
July 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Dermatology, University Hospital Schleswig Holstein, Campus Kiel
Kiel, Germany, 24105